Measuring Health-Related Quality of Life with Multimodal Data
In July 2021, I was part of a workshop that discussed how digital measurement of multiple modalities could be used to assess Quality of Life. A paper detailing the findings of the workshop was published in May 2022. The findings are summarised here.
Can digital health reduce the treatment burden on patients?
Comprehensive neuropsychological testing typically takes hours to complete, which can be mentally and physically burdensome for patients. Furthermore, the travel required and overall time-commitment to undergo these procedures within a clinic can result in decreased study compliance. Together these factors can confound conclusions concerning treatment efficacy. Here we will discuss how digital health can reduce these burdens when implementing therapeutic interventions to improve patient outcomes.
Wearable devices: the future for near-patient testing?
Cognition Kit and Takeda have collaborated to deliver high frequency assessments of mood and cognition in major depressive disorder, using the Apple Watch.